Michael Hedrick

Statistics

Publications

Citations

331

H-Index

Active since

2007

Affiliations

Sanford Burnham Prebys Medical Discovery Institute(Current)

University of Kansas

Justus-Liebig-Universität Gießen

Wayne State University

Neurocrine Biosciences (United States)

Michael Hedrick is an author at Sanford Burnham Prebys Medical Discovery Institute specializing in drug discovery, pharmacology, and medicinal chemistry.

Publications per year

2007–2018

Publications

Discovery of 4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate (ML221) as a functional antagonist of the apelin (APJ) receptor

Patrick Maloney, Pasha M. Khan, Michael Hedrick et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 62 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Identification and Characterization of Novel Human Glucose-6-Phosphate Dehydrogenase Inhibitors

Janina Preuss, Adam Richardson, Anthony B. Pinkerton et al. · SLAS DISCOVERY · 2012 · 61 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Potent, Selective, and Orally Available Benzoisothiazolone Phosphomannose Isomerase Inhibitors as Probes for Congenital Disorder of Glycosylation Ia

Russell Dahl, Yalda Bravo, Vandana Sharma et al. · Journal of Medicinal Chemistry · 2011 · 47 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

High-Throughput Screening for Small-Molecule Inhibitors of Plasmodium falciparum Glucose-6-Phosphate Dehydrogenase 6-Phosphogluconolactonase

Janina Preuss, Michael Hedrick, Eduard Sergienko et al. · SLAS DISCOVERY · 2012 · 31 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Screening for Selective Ligands for GPR55 - Antagonists

Susanne Heynen‐Genel, Russell Dahl, Shenghua Shi et al. · Europe PMC (PubMed Central) · 2011 · 27 citations

Medicine, Medicinal Chemistry, Pharmacology +15

1–5 of 12